Results 91 to 100 of about 32,721 (222)

Societal costs due to meningococcal disease: a national registry-based study

ClinicoEconomics and Outcomes Research, 2018
Nina Gustafsson,1 Sandra Elkjær Stallknecht,1 Mette Skovdal,2 Peter Bo Poulsen,3 Lars Østergaard4 1Incentive, Holte, Denmark; 2Vaccines, Pfizer Denmark, Ballerup, Denmark; 3Health and Value, Pfizer Denmark, Ballerup, Denmark; 4Department of ...
Gustafsson N, Stallknecht SE, Skovdal M, Poulsen PB, Østergaard L   +4 more
doaj  

Meningococcal disease. Polysaccharide meningococcal vaccines. The historical aspects and the current state of vaccine development. Report 2

Биопрепараты: Профилактика, диагностика, лечение, 2018
The present article describes clinical signs of meningococcal disease. It justifies the necessity of its vaccine prevention. The article provides with the historical data on the evolution of inoculants from corpuscular inactivated vaccines to modern ...
M. V. Abramtseva, A. P. Tarasov, T. I. Nemirovskaya   +2 more
doaj  

Differences in IgG Fc Glycosylation Are Associated with Outcome of Pediatric Meningococcal Sepsis

mBio, 2018
Pediatric meningococcal sepsis often results in morbidity and/or death, especially in young children. Our understanding of the reasons why young children are more susceptible to both the meningococcal infection itself and a more fulminant course of the ...
Noortje de Haan, Navin P. Boeddha, Ebru Ekinci, Karli R. Reiding, Marieke Emonts, Jan A. Hazelzet, Manfred Wuhrer, Gertjan J. Driessen   +7 more
doaj   +1 more source

Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease

Therapeutics and Clinical Risk Management, 2008
Sanford R KimmelUniversity of Toledo College of Medicine, Department of Family Medicine, Toledo, OH, USAAbstract: Invasive meningococcal disease occurs worldwide causing an estimated 50,000–135,000 deaths each year in addition to significant ...
Sanford R Kimmel
doaj  

Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination

Human Vaccines & Immunotherapeutics, 2019
Invasive meningococcal disease (IMD) caused by Neisseria meningitidis is characterized by high mortality and morbidity. While IMD incidence peaks in both infants and adolescents/young adults, carriage rates are often highest in the latter age groups ...
Cynthia Burman, Lidia Serra, Charles Nuttens, Jessica Presa, Paul Balmer, Laura York   +5 more
doaj   +1 more source

Fatal case of serogroup B meningococcal disease [PDF]

Wednesday, November 26, 2003, 007:25 EST (07:25 AM EST)CDCHAN-00166-03-11-26-ADV-NA fatal case of serogroup B meningococcal disease occurred in a 23 year old male who participated in a recent protest at the FTAA (Free Trade Area of the Americas) meeting ...

core  

Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

Infection and Drug Resistance, 2011
Michael Bröker, Brian Cooper, Lisa M DeTora, Jeffrey J StoddardGlobal Medical Affairs, Novartis Vaccines and Diagnostics, Marburg, Germany, and Cambridge, MA, USAAbstract: Worldwide, invasive meningococcal disease affects about 500,000 people ...
Bröker M, Cooper B, DeTora LM, Stoddard JJ   +3 more
doaj  

Infectious diseases: meningococcal disease

Western Journal of Medicine, 2000
This article comes from Clinical Evidence (2000;3:350-357), a new resource for clinicians produced jointly by the BMJ Publishing Group and theAmerican College of Physicians—American Society of Internal Medicine.Clinical Evidence is an extensively peer-reviewed publication that summarizes the best available evidence on the effects of common clinical ...
openaire   +3 more sources

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source